Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-15-074926
Filing Date
2015-10-08
Accepted
2015-10-08 21:49:41
Documents
1
Period of Report
2015-10-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 8011
  Complete submission text file 0001209191-15-074926.txt   9467
Mailing Address 12255 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130
Business Address 12255 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130 212-983-1310
Retrophin, Inc. (Issuer) CIK: 0001438533 (see all company filings)

EIN.: 262383102 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O RETROPHIN, INC., 777 THIRD AVENUE, 2 NEW YORK NY 10017
Business Address
Shih Alvin (Reporting) CIK: 0001610064 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36257 | Film No.: 151151888